Biochemistry

Special Issues

Following special issues within this section are currently open for submissions:

• Activations of Cadherin Signaling in Cancer 2.0 (Deadline: 30 October 2021)
• The Role of Stem Cells in Multiple Sclerosis (Deadline: 31 October 2021)
• Dry Eye Disease–Focus on Drug Discovery and Development (Deadline: 31 October 2021)
• Frontiers in Chemical Tools for Targeted Cancer Therapy (Deadline: 31 October 2021)
• Biotechnology-Recent Advances (Deadline: 31 October 2021)
• Molecular Mechanisms of Sjögren's Syndrome 2.0 (Deadline: 31 October 2021)
• Neurotransmitters and Neuropeptides in the Modulation of the Carotid Body 2.0 (Deadline: 31 October 2021)
• Transcription Factors Involved in Neurological Disorders and Tumors (Deadline: 31 October 2021)
• New Challenges in Human & Animal Vaccines (Deadline: 31 October 2021)
• Heterocyclic Compounds: Advanced Syntheses and Applications (Deadline: 31 October 2021)
• mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging (Deadline: 31 October 2021)
• Advances in Endocrine Disruptors (Deadline: 31 October 2021)
• Skin Histopathology: Focused on Ageing and Cancer (Deadline: 31 October 2021)
• Atherosclerosis and Other Related-Arterial Diseases (Deadline: 31 October 2021)
• Tumors of the Nervous System: New Insights into Signaling, Genetics and Therapeutic Targeting 2.0 (Deadline: 31 October 2021)
• Na+/K+ ATPase in Regulation of Blood Pressure (Deadline: 31 October 2021)
• Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations 2.0 (Deadline: 31 October 2021)
• Universe of DyP-type Peroxidase (Deadline: 31 October 2021)
• Regulation of Metabolism by Cell Cycle Regulators (Deadline: 31 October 2021)
• Recent Advances in Molecular Research of Metabolic Disorders (Deadline: 31 October 2021)
• Calcium Signaling in Human Health and Diseases 3.0 (Deadline: 10 November 2021)
• Pharmacological and Optogenetic Models of Arrhythmogenesis (Deadline: 30 November 2021)
• Molecular Mechanisms of Skin Aging and Atopic Dermatitis (Deadline: 30 November 2021)
• Role of Phosphodiesterase in Biology and Pathology 2.0 (Deadline: 30 November 2021)
• Mechanisms of Molecular Motor Triggered Cell Motility (Deadline: 30 November 2021)
• Membrane Proteins: Structure, Function and Motion (Deadline: 30 November 2021)
• Steroid Hormones and Sex Difference in Diseases (Deadline: 30 November 2021)
• Epithelial-Mesenchymal Transition (EMT) 2021 (Deadline: 30 November 2021)
• Recent Advances of Neural Networks: From Molecular Mechanisms to Therapeutic Exploitation (Deadline: 30 November 2021)
• Carbonic Anhydrase and Biomarker Research 2021 (Deadline: 30 November 2021)
• Recent Advances in Molecular Mechanisms of Kidney Injury and Repair (Deadline: 30 November 2021)
• Stress Signalling and Cell Death (Deadline: 30 November 2021)
• Sphingolipids: Signals and Disease 2.0 (Deadline: 30 November 2021)
• Group I Metabotropic Glutamate Receptors: Physiological and Pathological Roles (Deadline: 30 November 2021)
• Metabolic Basis of Inflammation and Carcinogenesis in Digestive Disorders (Deadline: 30 November 2021)
• Myogenesis and Muscular Disorders (Deadline: 30 November 2021)
• Mitochondrial Bioenergetics in Different Pathophysiological Conditions 2.0 (Deadline: 30 November 2021)
• Comprehensive Approach to Gastrointestinal Disorders (Deadline: 30 November 2021)
• Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications (Deadline: 30 November 2021)
• Role of Stromal Cell Population in Myocardial Remodelling (Deadline: 30 November 2021)
• Notch Signaling in Blood and Lymphatic Vascular Anomalies (Deadline: 30 November 2021)
• Calcium Channels and Calcium-Binding Proteins (Deadline: 30 November 2021)
• Retina Degeneration, Neuroprotection and Repair (Deadline: 30 November 2021)
• Molecular Mechanisms of Schizophrenia and Novel Targets (Deadline: 30 November 2021)
• Glucocorticoids and Metabolic Disorders (Deadline: 30 November 2021)
• Recent Progress in Multiple Sclerosis (Deadline: 30 November 2021)
• Endoplasmic Reticulum Stress and Unfolded Protein Response 2021 (Deadline: 30 November 2021)
• Protein and Nucleotide Engineering for Diagnoses and Biosensing (Deadline: 30 November 2021)
• Cytoprotective Effects of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Related Peptides (Deadline: 30 November 2021)
• Homeostasis and Cancer Initiation: New Insights into the Gastric Mucosa (Deadline: 30 November 2021)
• TRPM Channels (Deadline: 1 December 2021)
• Stem Cells from Dental Sources: Translational Applications in Medicine and Novel Approaches 2.0 (Deadline: 15 December 2021)
• Mechanisms of ER Protein Import (Deadline: 15 December 2021)
• Nitric and Nitrous Oxides: Biological and Environmental Significance (Deadline: 15 December 2021)
• Designed and Engineered Metalloenzymes: Strategies and Applications (Deadline: 20 December 2021)
• Advances in Antibody Design and Antigenic Peptide Targeting 2.0 (Deadline: 28 December 2021)
• Neuroinflammation and Cell Death: What Is New? (Deadline: 31 December 2021)
• Activity, Function and Druggability of Cancer-Related Enzymes (Deadline: 31 December 2021)
• Hedgehog Signaling 3.0 (Deadline: 31 December 2021)
• Animal and Plant Cell–Tissue, Organ Specialization and Function: Investigational, Experimental and Medical Aspects 2.0 (Deadline: 31 December 2021)
• Molecular Aspects of Degeneration and Regeneration in the Peripheral Nervous System (Deadline: 31 December 2021)
• Lipidomics and Neurodegenerative Diseases 2.0 (Deadline: 31 December 2021)
• Proteomics and Metabonomics for Personalised Medicine (Deadline: 31 December 2021)
• Role of Nrf2/Keap1 Signaling Pathway in Human Diseases (Deadline: 31 December 2021)
• Calcium-Binding Proteins and Cell Signaling 3.0 (Deadline: 31 December 2021)
• Mitochondria and Cancer (Deadline: 31 December 2021)
• Autophagy in Health, Aging and Disease 3.0 (Deadline: 31 December 2021)
• Functional Defects of Keratinocytes in Inflammatory Skin Diseases (Deadline: 31 December 2021)
• Sphingolipid Metabolism and Signaling in Diseases 2.0 (Deadline: 31 December 2021)
• Dysregulation of Human Molecular and Metabolic Mechanisms Resulting in Oxidative Stress and Damage Generation in the Space Environment (Deadline: 31 December 2021)
• Inflammation and Resolution in Endometriosis: From Science to Clinic (Deadline: 31 December 2021)
• Autophagy and Age-Associated Pathologies (Deadline: 31 December 2021)
• Cardiovascular Diseases–a Focus on Atherosclerosis, Its Prophylaxis, Complications and Recent Advancements in Therapies (Deadline: 31 December 2021)
• Salivary Biomarkers and Their Application to Diagnosis and Monitoring Human Diseases 2.0 (Deadline: 31 December 2021)
• Mitochondrial Disease and Therapy (Deadline: 31 December 2021)
• Cellular and Molecular Mechanisms in Glomerulonephritis 2.0 (Deadline: 31 December 2021)
• Enzymology of Respiration and Photosynthesis Processes (Deadline: 31 December 2021)
• Magnesium in Development and Aging (Deadline: 31 December 2021)
• Nanotechnology for Drug Delivery (Deadline: 31 December 2021)
• Mechanosensitive Ion Channels in Health and Disease (Deadline: 31 December 2021)
• PPARs as Key Mediators of Metabolic and Inflammatory Regulation (Deadline: 31 December 2021)
• Natural or Induced Thymic Senescence, Regenerative or Replacement Possibilities (Deadline: 31 December 2021)
• Molecular Recognition in Biopharmaceutical Development and Manufacturing (Deadline: 31 December 2021)
• Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors (Deadline: 31 December 2021)
• Multiple Enzyme Mechanism and Functions in Mitochondrial Biology (Deadline: 31 December 2021)
• Protein Glycation in Food, Nutrition, Health and Disease (Deadline: 31 December 2021)
• Ca²⁺-Activated Chloride Channels and Phospholipid Scramblases (Deadline: 31 December 2021)
• Novel Biorelevant Intestinal Epithelial In Vitro Models (Deadline: 31 December 2021)
• Imaging and Treating Tumors Overexpressing TSPO (Deadline: 31 December 2021)
• Molecular and Biological Mechanisms of Longevity (Deadline: 31 December 2021)
• Heme- and Hemoglobin Stress in Human Diseases 2.0 (Deadline: 31 December 2021)
• Microbial Esterases: Genomics, Physiology, Structure, and Applications (Deadline: 31 December 2021)
• The Role of Exosomes in Health and Disease (Deadline: 31 December 2021)
• Advancements in Protease and Carbonic Anhydrase Inhibitors as Targeted Therapies in Infection and Disease (Deadline: 16 January 2022)
• Different Strategies for Osteogenic Differentiation and Bone Regeneration 2021 (Deadline: 31 January 2022)
• Synthesis and Transformations of Bioactive Hydroxyquinolines (Deadline: 31 January 2022)
• Membrane Trafficking in Proliferative Diseases (Deadline: 31 January 2022)
• Mechanisms of Disease Progression and Drug Resistance in Myeloid Malignancies (Deadline: 31 January 2022)
• Ubiquitination in Health and Diseases: Volume II (Deadline: 31 January 2022)
• Therapeutic Drugs Targeting DNA (Deadline: 31 January 2022)
• Cellular and Molecular Biology in Autoimmune Disease (Deadline: 31 January 2022)
• RNA Modification Dynamics in Cellular Dysregulation and Clinical Diseases (Deadline: 31 January 2022)
• Gut Hormone: From Molecular Mechanism to Clinical Aspects 2021 (Deadline: 31 January 2022)
• Metabolomics in Health and Disease (Deadline: 31 January 2022)
• New Molecular Designs for Drugs including Potential Antibiotics (Deadline: 31 January 2022)
• Mitochondria-Targeted Approaches in Health and Disease 2.0 (Deadline: 31 January 2022)
• Mesenchymal Stem/Progenitor Cells and Their Derivates in Tissue Regeneration (Deadline: 31 January 2022)
• Antioxidant Therapies in Acute and Chronic Neurodegenerations (Deadline: 31 January 2022)
• Biotechnological Application of Carbohydrate Active Enzymes (Deadline: 31 January 2022)
• Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology 2.0 (Deadline: 31 January 2022)
• Cellular and Molecular Mechanisms of Ozone Therapy: Present Knowledge and Prospective Applications (Deadline: 31 January 2022)
• Biological Systems at the Protein Level 2.0 (Deadline: 31 January 2022)
• Mitochondrial Health and Small Organic Molecules/Natural Products (Deadline: 31 January 2022)
• Liver Organoids in Regenerative Medicine (Deadline: 31 January 2022)
• Acute Kidney Injury and Chronic Kidney Diseases (Deadline: 31 January 2022)
• Calcium Channel Regulation in Cancer: Unravelling the Molecular Mechanisms beneath the Membrane (Deadline: 1 February 2022)
• Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs (Deadline: 10 February 2022)
• Immune Cells in Allergy and Inflammation (Deadline: 28 February 2022)
• The Endosomal-Lysosomal System: A Dynamic Network of Molecular and Cellular Pathways (Deadline: 28 February 2022)
• Molecular Regulation of the Endomembrane System 2.0 (Deadline: 28 February 2022)
• Yeast Cell Signalling Pathways (Deadline: 28 February 2022)
• The Multiple and Dynamic Faces of Protein Structure: Folded States, Intrinsically Unfolded States, and Aggregates/Fibrils (Deadline: 28 February 2022)
• Molecular Signaling Pathways in Brain Pathology (Deadline: 28 February 2022)
• Vitamin C and Carbohydrates in Human Physiology: Mechanism of Action (Deadline: 28 February 2022)
• Extracellular Vesicles and Cell–Cell Communication 2.0 (Deadline: 28 February 2022)
• Understanding the Molecular Mechanisms of Retinal Ganglion Cell Death after Optic Nerve Damage (Deadline: 28 February 2022)
• Huntingtin: Interacting Proteins, Degradation, Post-Translational Modifications (Deadline: 28 February 2022)
• The Role of the Tumor Microenvironment in Cancer (Deadline: 28 February 2022)
• Liver–Gut Axis 2.0 (Deadline: 28 February 2022)
• Osteoclastogenesis and Osteogenesis 2.0 (Deadline: 28 February 2022)
• Metal Homeostasis and Transport: Novel Chemistry Related to Human Diseases (Deadline: 28 February 2022)
• Non-coding Small RNAs (sRNAs) in Prokaryotic Systems (Deadline: 28 February 2022)
• Role of Ion-Channels in Signal Transduction and Gene Regulation (Deadline: 28 February 2022)
• Complex Carbohydrates and Glycoconjugates: Structure, Functions and Applications 2021 (Deadline: 28 February 2022)
• Molecular Mechanisms Underlying Stress Response and Resilience (Deadline: 28 February 2022)
• Small Molecule Drug Design and Research (Deadline: 28 February 2022)
• Nitric Oxide Synthases: Regulation and Function 2021 (Deadline: 28 February 2022)
• Role of Soluble Beta Amyloid in the Depressive Disorders (Deadline: 28 February 2022)
• ERAD and Ubiquitination 2.0 (Deadline: 28 February 2022)
• Small Prokaryotic Proteins Interacting with Nucleic Acids (Deadline: 28 February 2022)
• Implication of Ion Channels in Neurodevelopmental Disorders (Deadline: 28 February 2022)
• STIMulating Ca2+ Homeostasis 2.0 (Deadline: 10 March 2022)
• Neuromelanin, Peripheral Melanin and Parkinson's Disease (Deadline: 31 March 2022)
• Metal Ions in Cancer (Deadline: 31 March 2022)
• Data Mining and Bioinformatic Tools for Health (Deadline: 31 March 2022)
• Physiological and Pathophysiological Functions of a Wide-Spread Superfamily of Metalloenzymes Known as Carbonic Anhydrases (CA) (Deadline: 31 March 2022)
• Ubiquitination and Deubiquitination in Cellular Homeostasis (Deadline: 31 March 2022)
• Uncoupling Proteins (Deadline: 31 March 2022)
• MAPK in Health and Disease (Deadline: 31 March 2022)
• Nuclear Envelope Proteins 2.0 (Deadline: 31 March 2022)
• Tackling New and Reemerging Infectious Diseases through the Development of Novel Anti-infectives (Deadline: 31 March 2022)
• Molecular Interactions and Mechanisms of COVID-19 Inhibition (Deadline: 31 March 2022)
• The Molecules and Stem Cells in Bone Regeneration (Deadline: 31 March 2022)
• Plasma-Activated Seed Germination (Deadline: 31 March 2022)
• Redox Modulation by Antioxidants, Seen through the Energy Perspective (Deadline: 31 March 2022)
• Molecular Research on Eryptosis (Deadline: 31 March 2022)
• Electron Microscopy for Hydrophilic Specimen and Related Measurements (Deadline: 31 March 2022)
• Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0 (Deadline: 31 March 2022)
• Growth Hormone Axis and Stress Biology (Deadline: 31 March 2022)
• Progress on Multidrug Resistance Mechanisms in Cancer (Deadline: 31 March 2022)
• Lipids: From the Structure, Function and Evolution to Applications (Deadline: 31 March 2022)
• Modulation of Protein Structure and Function by Lipids (Deadline: 31 March 2022)
• Membranous Nanostructures - Micro World Communication Infrastructure (Deadline: 31 March 2022)
• The Interplay of Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches (Deadline: 31 March 2022)
• Ways to Model Neurologic Disorders: New Insights (Deadline: 30 April 2022)
• Emerging Roles of Microtubule-Associated Serine/Threonine (MAST) Kinases in Cell Biology and Biomedical Research (Deadline: 30 April 2022)
• Inflammation in Health and Disease: New Insights and Therapeutic Avenues 2.0 (Deadline: 30 April 2022)
• Protective and Detrimental Role of Heme Oxygenase-1: 2021 (Deadline: 30 April 2022)
• New Molecular Mechanisms and Markers in Inflammatory Disorders (Deadline: 30 April 2022)
• Drug Discovery and Novel Platelet Signaling in Thrombogenesis (Deadline: 30 April 2022)
• Biogenesis and Regulation of Complex Membrane Domains (Deadline: 30 April 2022)
• Recent Advances in Biological Functions of Platelet (Deadline: 30 April 2022)
• Nanoparticles and Other Nanostructures and the Control of Pathogens: From Bench to Vaccines (Deadline: 30 April 2022)
• Therapeutic Targeting of the Proteolytic Enzymes (Deadline: 30 April 2022)
• Mitochondria and Mitochondrial Derived Peptides (Deadline: 30 April 2022)
• Novel Biomarkers and Therapeutic Targets for Melanoma (Deadline: 30 April 2022)
• Neurobiology of Zinc (Deadline: 30 April 2022)
• PD-L1, a Master Regulator of Immunity 2.0 (Deadline: 30 April 2022)
• Nano-Strategies: The Future Medicine for Fighting Cancer Progression and Drug Resistance 2.0 (Deadline: 30 April 2022)
• Photosynthesis 2.0 (Deadline: 30 April 2022)
• Esterases in the Circulatory System: Structure, Function, Activity Modulation and Involvement in Pathology (Deadline: 30 April 2022)
• miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics 2.0 (Deadline: 31 May 2022)
• Oxidative Stress: Focusing on New Therapeutic Approaches and Biochemical Markers (Deadline: 31 May 2022)
• Recent Developments in Ion Channel and Ion-Related Signaling (Deadline: 31 May 2022)
• Molecular Biomarkers of Selected Diseases of Civilization 2.0 (Deadline: 31 May 2022)
• Flavonoids and Other Polyphenols in Health and Disease (Deadline: 30 June 2022)
• Signal Transduction 2.0: From Molecular Pathways to Translational Research (Deadline: 31 July 2022)
• Current Topics in Trace Element and Mineral Research (Deadline: 30 September 2022)
• Chemistry towards Biology (Deadline: 30 September 2022)
• Mitochondrial Biogenesis and Metabolism in Gastrointestinal System Pathophysiology (Deadline: 30 September 2022)
• Sensing, Mechanistic, and Functional Roles of TRP Channels in Ocular Tissues (Deadline: 31 October 2022)
• Biochemistry, Molecular Biology and Druggability of Proteins (Deadline: 28 February 2023)

Topical Collections

Following topical collections within this section are currently open for submissions:

• 21st Anniversary of IJMS: Advances in Biochemistry
• Advances in Proteomic Research
• Antifungal Compounds
• Biocatalysis and Bioengineering
• Carbonic Anhydrase and Carbonic Anhydrase Inhibitors
• Feature Paper Collection in Biochemistry
• G Protein-Coupled Receptor Signaling and Regulation
• Protein Folding
• Proteins and Protein-Ligand Interactions